Table 1.
Details of the Matching of Cases and Controlsa
| Characteristic | GanR-CMV Cases (n = 37), No. (%) | GanS-CMV Controls (n = 109), No. (%) | P Value |
|---|---|---|---|
| CMV serostatus | |||
| D+/R− | 32 (86.5) | 97 (89.0) | .85 |
| D−/R− | 3 (8.1) | 6 (5.5) | |
| R+ | 2 (5.4) | 6 (5.5) | |
| Organ transplanted | |||
| Lung | 17 (45.6) | 52 (47.7) | .95 |
| Heart | 6 (16.2) | 20 (18.4) | |
| Kidney | 6 (16.2) | 19 (17.4) | |
| Pancreas | 6 (16.2) | 12 (11.0) | |
| Liver | 2 (5.4) | 6 (5.5) | |
| CMV manifestation | |||
| Refractory viremia | 7 (18.9) | 22 (20.2) | .99 |
| Syndrome | 11 (29.7) | 32 (29.4) | |
| Tissue-invasive | 19 (51.4) | 55 (50.5) | |
Abbreviations: CMV, cytomegalovirus; D, donor; ganR, ganciclovir resistant; ganS, ganciclovir sensitive; R, recipient.
aAll controls were also matched to cases by year of transplant ±3 years.